Bone and Renal health in infants with or without breastmilk exposure to Tenofovir based maternal antiretroviral treatment in the PROMISE randomized trial

Simple item page
dc.article.end-page437en
dc.article.start-page431en
dc.citation.doi10.1097/QAI.0000000000003218en
dc.contributor.authorVhembo, T.en
dc.contributor.authorBaltrusaitis, K.en
dc.contributor.authorTierney, C. en
dc.contributor.authorOwor, M.en
dc.contributor.authorViolari, Avyien
dc.date.accessioned2024-07-23T05:54:10Z
dc.date.available2024-07-23T05:54:10Z
dc.facultyFaculty of Health Sciencesen
dc.identifier.citationVhembo, T., Baltrusaitis, K., Tierney, C., Owor, M., Dadabhai, S., Violari, A., Theron, G., Moodley, D., Mukwasi-Kahari, C., George, K., Shepherd, J., Siberry, G. K., Browning, R., Fowler, M. G., Stranix-Chibanda, L., & IMPAACT P1084s study team (2023). Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial. Journal of Acquired Immune Deficiency Syndrome (1999), 93(5), 431–437.en
dc.identifier.issn1525-4135 (print)
dc.identifier.issn1077-9450 (online)
dc.identifier.urihttps://hdl.handle.net/10539/39025
dc.journal.issue5
dc.journal.titleJournal of Acquired Immune Deficiency Syndrome (JAIDS)en
dc.journal.volume93en
dc.publisherLippincott, Williams & Wilkins (LWW)
dc.rightsCopyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND).
dc.schoolSchool of Public Health
dc.subject.otherSDG-3: Good health and well-being
dc.titleBone and Renal health in infants with or without breastmilk exposure to Tenofovir based maternal antiretroviral treatment in the PROMISE randomized trialen
dc.typeArticleen

Files

Collections

School of Public Health (Journal Articles)